United Therapeutics | UTHR - 流动负债



金融业
股票价格
USD 593.54
资产
USD 7.22B
现金及等价物
USD 1.8B
销售成本
USD 99.5M
流动资产
USD 3.48B
流动负债
USD 607.8M
债务
USD 200M
EBIT
USD 375.6M
EBITDA
USD 355M
员工
1.31K
EPS每股收益
USD 7.27
股本和储备
USD 6.4B
销售毛利
USD 683.8M
债务利息支出
USD 2.9M
利息收入
USD 31.5M
贷款资金
USD 100M
市值
USD 27.96B
净收入
USD 333M
营业费用
USD 6.4B
营业利润
USD 330.8M
普通股股本
USD 42.68M
PE价格收益
19.15
税前利润
USD 372.7M
销售收入
USD 783.3M
销售和管理费用
USD 206.7M
股票
USD 193.8M
贸易债权人
USD 497.8M
应收帐款人
USD 310.3M


流动负债 更改 日
Amarin USD 175.14M 10.94M 2026-09
Ardelyx USD 109.57M 20.96M 2026-03
Baxter International USD 3.81B 218M 2026-09
Bayer EUR 32.27B 1.19B 2026-06
BioCryst Pharmaceuticals USD 208.85M 13.46M 2026-06
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
Insmed USD 596.57M 157.83M 2026-09
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
J&J USD 55.46B 562M 2026-09
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
Moderna USD 2.53B 139M 2026-06
Omeros USD 85.5M 2.28M 2025-06
Pfizer USD 32.65B 1.7B 2026-06
PTC Therapeutics USD 776.08M 5.01M 2026-09
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Teva Pharmaceutical Industries USD 15.65B 2.11B 2026-06
United Therapeutics USD 607.8M 8.7M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06